Related Experiment Videos
Finnish physicians' interest in genetic screening.
1National Research and Development Centre for Welfare and Health (STAKES), Health and Social Services, PO Box 220, FIN-00531 Helsinki (Finland). hanna.toivianentakes.fi
Community Genetics
|August 9, 2001
Summary
Finnish physicians favor targeted genetic screening for specific diseases over broad population-wide testing. They expressed interest in knowing their own disease risks, influencing their views on genetic screening procedures.
Area of Science:
- Medical Genetics
- Public Health Policy
- Physician Education
Background:
- Genetic screening offers potential for early disease detection and prevention.
- Understanding physician perspectives is crucial for implementing new healthcare technologies.
- Physician attitudes towards genetic screening can influence patient uptake and healthcare system integration.
Purpose of the Study:
- To assess Finnish physicians' views on future genetic screening applications.
- To gauge physicians' interest in their personal genetic disease risk.
- To inform policy and practice regarding genetic screening implementation.
Main Methods:
- A cross-sectional questionnaire survey was distributed to various physician specialties in Finland.
- The survey included questions on preferences for genetic testing targets and personal risk information.
- A response rate of 74% (n=571) was achieved, encompassing leading and other practitioners.
Main Results:
- Physicians preferred targeted genetic testing for individuals with a family history over general population screening.
- Screening was most valued for breast cancer, colon cancer, familial hypercholesterolaemia, and juvenile diabetes.
- Physicians' support for screening correlated with their interest in knowing their own disease risk.
Conclusions:
- Physicians are not broadly enthusiastic about widespread genetic screening.
- There is a likelihood of increased genetic testing for individuals with a family history of specific diseases.
- Physician opinions are nuanced, varying by disease and target population.